Mesoblast Ltd at Edison Open House Global Healthcare Conference (Virtual) Transcript
Welcome to Edison Open House Global Healthcare 2022. In this session, we are focusing on the work of Mesoblast, an Australian cellular medicine company, and we have Silviu Itescu, it's CEO, with us.
Questions & Answers
Silviu, hello. And can you tell us what does Mesoblast do?
Thanks for having me. Mesoblast is developing a variety of therapies based on off-the-shelf cellular medicines that are able to sense inflammation and can be used to turn off damaging inflammation in some very, very serious diseases. The key element here is that the cells can be used off-the-shelf, they're sourced from healthy young donors, they're batched, they're expanded, and they're released we're using very strict criteria so that every vial is the same as the same release criteria, and we're able to ensure that the potency of each product meets prespecified regulatory requirements so that
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
